✦ LIBER ✦

Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma

✍ Scribed by Ying-Wen Su; Ming-Chih Chang; Ming-Fu Chiang; Ruey-Kuen Hsieh

Publisher: Springer US
Year: 2005
Tongue: English
Weight: 167 KB
Volume: 71
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-004-2028-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Temozolomide after Radiotherapy for Newl

Temozolomide after Radiotherapy for Newly Diagnosed High-grade Glioma and Unfavorable Low-grade Glioma in Children

✍ Alberto Broniscer; Murali Chintagumpala; Maryam Fouladi; Matthew J. Krasin; Mehm 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 186 KB

Interstitial radiogold implantation for

Interstitial radiogold implantation for the treatment of recurrent high-grade gliomas

✍ Gary L. Larson; John H. Wilbanks; W. Sam Dennis; William D. Permenter; James D. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 1 views

Temozolomide for recurrent or progressiv

Temozolomide for recurrent or progressive high-grade malignant glioma: Results of an Austrian multicenter observational study

✍ Marco Hassler; Michael Micksche; Günther Stockhammer; Josef Pichler; Franz Payer 📂 Article 📅 2006 🏛 Springer Vienna 🌐 English ⚖ 174 KB

Combination of 6-thioguanine, capecitabi

Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma

✍ Tobias Walbert; Mark R. Gilbert; Morris D. Groves; Vinay K. Puduvalli; W. K. Alf 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 231 KB

Multi-institutional phase II study of te

Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas

✍ Casilda Balmaceda; David Peereboom; Susan Pannullo; Ying Kuen K. Cheung; Paul G. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract ## BACKGROUND. The prognosis for patients with recurrent high‐grade gliomas is poor and treatment options are limited. Current chemotherapeutic regimens can improve clinical outcomes, but extend survival by only a few months. Temozolomide is a methylating agent that is typically admini

Administration of temozolomide during an

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

✍ Giuseppe Luigi Banna; Daniela Bettio; Marta Scorsetti; Pierina Navarria; Matteo 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 86 KB